By Professor David Thomas

Other

Thomas DM; Kim JE; Barlesi F; Martens UM; Krzakowski M; Dziadziuszko R; Jeong JH; Daniele G; Wilson TR; Wu F; Simmons BP; Patel S; Sbirnac M; Kaul M; Gadgeel SM, 2026, Table 5 from TAPISTRY: A Phase II Study of Atezolizumab in Patients with Tumor Mutational Burden–High Tumors, http://dx.doi.org/10.1158/1078-0432.31744536

Back to profile page